1027019-12-0 Usage
Classification
Monoamine oxidase inhibitor (MAOI)
Medical Use
Treatment of depression and anxiety disorders
Mechanism of Action
Increases levels of serotonin and dopamine in the brain
Physical Form
White to off-white crystalline powder
Solubility
Soluble in water
Route of Administration
Orally in tablet form
Potential Drug Interactions
Can interact with certain foods, beverages, and other medications
Caution
Should only be used under the supervision of a healthcare professional
Check Digit Verification of cas no
The CAS Registry Mumber 1027019-12-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,7,0,1 and 9 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1027019-12:
(9*1)+(8*0)+(7*2)+(6*7)+(5*0)+(4*1)+(3*9)+(2*1)+(1*2)=100
100 % 10 = 0
So 1027019-12-0 is a valid CAS Registry Number.
1027019-12-0Relevant articles and documents
Organocatalytic syntheses of benzoxazoles and benzothiazoles using aryl iodide and oxone via C-H functionalization and C-O/S bond formation
Alla, Santhosh Kumar,Sadhu, Pradeep,Punniyamurthy, Tharmalingam
, p. 7502 - 7511 (2014/09/16)
An organocatalytic protocol for the syntheses of 2-substituted benzoxazoles and benzothiazoles is described from alkyl-/arylanilides and alkyl-/arylthioanilides using 1-iodo-4-nitrobenzene as catalyst and oxone as an inexpensive and environmentally safe terminal oxidant at room temperature in air via oxidative C-H functionalization and C-O/S bond formation. The procedure is simple and general and provides an effective route for the construction of functionalized 2-alkyl-/arylbenzoxazoles and 2-alkyl-/arylbenzothiazoles with moderate to high yields. The synthetic and mechanistic aspects have been described.
